| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 122, 481-487, Copyright © 1986 by American Society for Investigative Pathology
REGULAR ARTICLES |
JR Diamond and MJ Karnovsky
Focal and segmental glomerulosclerosis (FSGS) represents a final pathologic pattern of a number of human renal disorders. Among laboratory models, repeated intraperitoneal injections of the aminonucleoside of puromycin (PA) produces a histologic pattern not unlike the human process. A single intravenous dose of this drug usually results in glomerular morphologic changes in rats resembling those in human nephrotic syndrome with minimal changes. This report describes acute and chronic glomerular injury that begins as early as 8 days after a single central administration of PA and progresses to FSGS within an 18-week period. It seems likely that minimal change disease and FSGS are two pathologic processes in the same continuum of disease. In this model, the severity and persistence of the glomerular lesion may represent irreversible glomerular epithelial cell (GEC) injury secondary to the toxic effects of PA.
This article has been cited by other articles:
![]() |
Y. Harita, N. Miyauchi, T. Karasawa, K. Suzuki, G. D. Han, H. Koike, T. Igarashi, F. Shimizu, and H. Kawachi Altered expression of junctional adhesion molecule 4 in injured podocytes Am J Physiol Renal Physiol, February 1, 2006; 290(2): F335 - F344. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. He, M. Imai, H. Song, R. J. Quigg, and S. Tomlinson Complement Inhibitors Targeted to the Proximal Tubule Prevent Injury in Experimental Nephrotic Syndrome and Demonstrate a Key Role for C5b-9 J. Immunol., May 1, 2005; 174(9): 5750 - 5757. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsusaka, J. Xin, S. Niwa, K. Kobayashi, A. Akatsuka, H. Hashizume, Q.-c. Wang, I. Pastan, A. B. Fogo, and I. Ichikawa Genetic Engineering of Glomerular Sclerosis in the Mouse via Control of Onset and Severity of Podocyte-Specific Injury J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1013 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Erdely, G. Freshour, C. Smith, K. Engels, J. L. Olson, and C. Baylis Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat Am J Physiol Renal Physiol, July 1, 2004; 287(1): F81 - F89. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Watanabe, T. Kobayashi, E. Yaoita, H. Kawachi, A. Yamauchi, T. Inoue, F. Shimizu, Y. Yoshida, A. G. A. El-shemi, H. Okada, et al. Novel expression of sodium/myo-inositol co-transporter in podocytes in puromycin aminonucleoside nephrosis Nephrol. Dial. Transplant., April 1, 2004; 19(4): 817 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Sanden, J. E. Wiggins, M. Goyal, L. K. Riggs, and R. C. Wiggins Evaluation of a Thick and Thin Section Method for Estimation of Podocyte Number, Glomerular Volume, and Glomerular Volume Per Podocyte in Rat Kidney with Wilms' Tumor-1 Protein Used as a Podocyte Nuclear Marker J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2484 - 2493. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pavenstadt, W. Kriz, and M. Kretzler Cell Biology of the Glomerular Podocyte Physiol Rev, January 1, 2003; 83(1): 253 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Yaoita, J. Yao, Y. Yoshida, T. Morioka, M. Nameta, T. Takata, J.-i. Kamiie, H. Fujinaka, T. Oite, and T. Yamamoto Up-Regulation of Connexin43 in Glomerular Podocytes in Response to Injury Am. J. Pathol., November 1, 2002; 161(5): 1597 - 1606. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. MARKOWITZ, G. B. APPEL, P. L. FINE, A. Z. FENVES, N. R. LOON, S. JAGANNATH, J. A. KUHN, A. D. DRATCH, and V. D. D'AGATI Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1164 - 1172. [Abstract] [Full Text] |
||||
![]() |
M. Menjívar, M. Cárdenas, G. Ortiz, and J. Pedraza-Chaverrí Fertility Diminution in Female Rats with Experimental Chronic Nephrosis Biol Reprod, November 1, 2000; 63(5): 1549 - 1554. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |